Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0000950170-24-015559 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-02-14 | 2024-02-12 | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -1,501 | 451.5K | -0.3% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | S | D | 1,501 | $20.00 | 451,480 | D | — | — |